Categories: Business

Success at the Corona vaccine: Biontech and Pfizer fast high

Success at the Corona vaccine
Biontech and Pfizer fast high

Price jump for the shares of the Mainz biopharmaceutical company Biontech. Photo: Andreas Arnold/dpa

© dpa-infocom GmbH

The German manufacturer of Biontech and the US Corporation Pfizer present promising interim results of a large study for a Corona-Imfstoff. This has a prompt on the share prices.

The prospect of a vaccine against the Coronavirus has brought on Monday Pfizer and Biontech high price gains.

The papers of the US technology stock exchange Nasdaq-listed Mainz-based Biotech company Biontech jumped in the top 25 percent, to 115 US dollars upwards. However, you gave a part of those gains and were last with 10 percent. Shares of the Pharma heavyweight Pfizer increased by 8.7 percent.

An effective Corona vaccine in Europe and the USA is now within reach: As the first Western manufacturer Biontech and Pfizer published on Monday, promising results for the pivotal study. Thus, your vaccine provides more than 90 percent protection against the disease Covid-19. Serious side effects had not yet been registered, it was said by the two companies.

The more than 90 percent of the estimated efficiency is impressive, wrote Analyst Chris Schott from the investment Bank JPMorgan in a first reaction to the news. It suggests that there could be a breakthrough in the fight against the pandemic.

Efficacy of the vaccine candidates from more than 90 percent was higher than expected, wrote Analyst Carter Gould from Barclays Bank. The result should contribute to concerns about the effectiveness and the General Impfbereitschaft address. Other vaccines that are currently researched to combat the Virus and developed, could show a higher effectiveness than previously thought, said Gould.

Something of a cautious Analyst Zhiqiang Shu of the Berenberg Bank argued. The efficiency requirements of the US food and drug administration, FDA, is likely to be exceeded, with an effectiveness of 90 percent, although loose. In addition, it concerns so far, no serious security. There are other questions remained open, such as the duration of protection. Some of these questions could probably be answered after you have been admitted.

dpa
Matthew Velter

With 5 years of experience as an editor, Matthew has been a crucial part of eTrendy Stock since its inception. He looks after the editing of news content published on eTrendy Stock. Apart from investing his time in editing, he also provides well-researched news articles for the U.S. niche. Mathew studied at University of central Florida.

Recent Posts

Optimizely Security Breach Exposes 178 Organisations to Crypto Theft Attempts

London, UK, November 17, 2026 — A security breach involving website experimentation platform Optimizely exposed…

1 hour ago

Coinbase Launches ChatGPT Plugin Allowing Users to Trade Crypto Through Natural Language

San Francisco, USA, November 17, 2026 — Coinbase has introduced a plugin for ChatGPT that…

1 hour ago

CFTC Approvals Move Blockchain Based Derivatives Exchanges Closer to US Market Participation

Washington, DC, USA, November 17, 2026 — The US Commodity Futures Trading Commission has approved…

1 hour ago

Russia Allows Non-Qualified Investors to Access Bitcoin, Ether and USDT Under New Rules

Moscow, Russia, November 17, 2026 — New cryptocurrency access rules from the Bank of Russia…

1 hour ago

Solana Foundation Takes Majority Stake in CoinGecko, Expanding Its Reach Across Crypto Markets

London, UK, November 17, 2026 — The Solana Foundation has acquired a majority interest in…

1 hour ago

Al Wathba Insurance Goes Live with Agentic AI Marking a New Chapter in Its Digital Transformation

Al Wathba Insurance reports a 50% reduction in case turnaround time and an expansion of…

2 days ago